Financial results - PREMIUM PHARMA CONCEPT S.R.L.

Financial Summary - Premium Pharma Concept S.r.l.
Unique identification code: 45767047
Registration number: J2022004447403
Nace: 4773
Sales - Ron
1.097.366
Net Profit - Ron
57.956
Employees
9
Open Account
Company Premium Pharma Concept S.r.l. with Fiscal Code 45767047 recorded a turnover of 2024 of 1.097.366, with a net profit of 57.956 and having an average number of employees of 9. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Premium Pharma Concept S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - - - - 82.673 219.360 1.097.366
Total Income - EUR - - - - - - - 82.673 219.361 1.097.380
Total Expenses - EUR - - - - - - - 89.353 191.589 1.026.578
Gross Profit/Loss - EUR - - - - - - - -6.679 27.772 70.802
Net Profit/Loss - EUR - - - - - - - -7.506 25.248 57.956
Employees - - - - - - - 3 3 9
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 403.1%, from 219.360 euro in the year 2023, to 1.097.366 euro in 2024. The Net Profit increased by 32.849 euro, from 25.248 euro in 2023, to 57.956 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Premium Pharma Concept S.r.l.

Rating financiar

Financial Rating -
PREMIUM PHARMA CONCEPT S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Premium Pharma Concept S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Premium Pharma Concept S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Premium Pharma Concept S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Premium Pharma Concept S.r.l. - CUI 45767047

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - - - - 0 0 64.211
Current Assets - - - - - - - 33.671 87.304 488.210
Inventories - - - - - - - 17.239 26.918 202.901
Receivables - - - - - - - 4.517 57.293 244.677
Cash - - - - - - - 11.915 3.093 40.632
Shareholders Funds - - - - - - - -7.466 17.805 59.383
Social Capital - - - - - - - 0 0 0
Debts - - - - - - - 41.137 69.499 493.039
Income in Advance - - - - - - - 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 488.210 euro in 2024 which includes Inventories of 202.901 euro, Receivables of 244.677 euro and cash availability of 40.632 euro.
The company's Equity was valued at 59.383 euro, while total Liabilities amounted to 493.039 euro. Equity increased by 41.677 euro, from 17.805 euro in 2023, to 59.383 in 2024.

Risk Reports Prices

Reviews - Premium Pharma Concept S.r.l.

Comments - Premium Pharma Concept S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.